SEC62 and prostate carcinoma: Encoded in chromosomal region 3q26.2 the SEC62 oncogene was shown to be a relevant molecular target which is overexpressed in NSCLC, hepatocellular carcinoma, prostate cancer, cervical cancer, melanoma, and breast cancer (Jung et al., 2006; Weng et al., 2012; Hagerstrand et al., 2013; Linxweiler et al., 2016; Takacs et al., 2019; Casper et al., 2021; Müller et al., 2021; Sicking et al., 2021).